These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17030665

  • 1. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.
    Allen JA, Adlakha A, Bergethon PR.
    Arch Neurol; 2006 Oct; 63(10):1475-8. PubMed ID: 17030665
    [Abstract] [Full Text] [Related]

  • 2. [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
    Kuwada A, Nakamitsu A, Imamura Y, Kouyama M, Uekami S, Touge K, Taogoshi H, Fukuda Y, Daimaru H.
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2937-40. PubMed ID: 21160275
    [Abstract] [Full Text] [Related]

  • 3. Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab.
    Ozen A, Cicin I, Sezer A, Uzunoglu S, Saynak M, Genchellac H, Karagol H.
    J Cancer Res Ther; 2009 Dec; 5(2):130-2. PubMed ID: 19542672
    [Abstract] [Full Text] [Related]

  • 4. The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.
    Grothey E, Chu E.
    Clin Colorectal Cancer; 2007 Sep; 6(9):621-4. PubMed ID: 17945033
    [No Abstract] [Full Text] [Related]

  • 5. Bevacizumab-associated reversible hypotension.
    Iqbal K, Chu Q, Mei Q, Chen Y.
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):800-1. PubMed ID: 17825542
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
    de Melo JV, Vieira de Melo MS, Abad MH.
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
    [Abstract] [Full Text] [Related]

  • 7. Efficient and safe application of a FOLFIRI/bevacizumab combination to a patient with locally advanced rectal cancer and severe chronic renal failure.
    Cicin I, Karagol H, Uzunoglu S, Uygun K.
    Onkologie; 2007 Feb; 30(1-2):65. PubMed ID: 17264528
    [No Abstract] [Full Text] [Related]

  • 8. Sequential or combination chemotherapy for a patient with mCRC?
    Arnold D.
    Cancer Treat Rev; 2008 Feb; 34 Suppl 2():S12-6. PubMed ID: 19101403
    [Abstract] [Full Text] [Related]

  • 9. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
    Abbrederis K, Kremer M, Schuhmacher C.
    Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.
    Mochizuki S, Yoshino T, Kojima T, Fuse N, Ikematsu H, Minashi K, Yano T, Tahara M, Kaneko K, Doi T, Koike K, Ohtsu A.
    Jpn J Clin Oncol; 2010 Oct; 40(10):933-7. PubMed ID: 20494948
    [Abstract] [Full Text] [Related]

  • 11. [A case of encephalopathy that was suspected to be caused by chemotherapy for colon cancer].
    Ganno H, Fujiya K, Nakamura M, Takasaki J, Watayoh Y, Amagasa H, Kurokawa T, Ami K, Fukuda A, Nagahama T, Andoh M, Arai K.
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2322-4. PubMed ID: 22202369
    [Abstract] [Full Text] [Related]

  • 12. Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen.
    Dedić Plavetić N, Rakušić Z, Ozretić D, Simetić L, Krpan AM, Bišof V.
    World J Surg Oncol; 2014 Aug 20; 12():264. PubMed ID: 25142792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Are antiangiogenic antibodies universal for solid tumor?].
    Ray-Coquard I, Bachelot T, Saba C, Confavreux C, Brantus JF, Rustam F, Ghesquière H, Sebban C, Biron P, Guastalla JP, Blay JY.
    Bull Cancer; 2007 Jul 20; 94 Spec No():S191-6. PubMed ID: 17846004
    [Abstract] [Full Text] [Related]

  • 16. Liver resection after FOLFOX with bevacizumab.
    Mickle M, Mulcahy MF.
    Clin Adv Hematol Oncol; 2007 Jan 20; 5(1 Suppl 1):12-4. PubMed ID: 17491587
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer.
    Katada E, Mitsui A, Sasaki S, Uematsu N, Anan C.
    Intern Med; 2018 Aug 15; 57(16):2403-2407. PubMed ID: 29526944
    [Abstract] [Full Text] [Related]

  • 20. Managing patients treated with bevacizumab combination therapy.
    Gordon MS, Cunningham D.
    Oncology; 2005 Aug 15; 69 Suppl 3():25-33. PubMed ID: 16301833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.